Skip to Content

'
Camilo Jimenez, M.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1995 Pontificia Universidad Javeriana, Santafe de Bogota, Colombia, MD, Medicine and Surgery

Postgraduate Training

1/2001-1/2004 Clinical Fellowship, Endocrinology, Diabetes and Metabolism, Baylor College of Medicine and The University of Texas M.D. Anderson Cancer Center, Houston, TX, Robert F. Gagel, MD
1/1999-1/2001 Clinical Residency, Internal Medicine, The University of Miami Jackson Memorial Hospital, Miami, FL
1/1998-1/1999 Clinical Internship, Internal Medicine, The University of Miami Jackson Memorial Hospital, Miami, FL
1/1996-1/1997 Clinical Residency, Internal Medicine, The National Cancer Institute, Santafe de Bogota, Colombia

Board Certifications

2007 Endocrinology, Diabetes and Metabolism
1/2002 American Board of Internal Medicine

Experience/Service

Academic Appointments

Adjunct Professor, The William J. Harrington Medical Training Program of Latin America, The University of Miami, Jackson Memorial Hospital, Miami, FL, 1/2007

Selected Publications

Peer-Reviewed Original Research Articles
1. Santarpia L, Habra MA, Jiménez C. Malignant Pheochromocytomas and Paragangliomas: Molecular Signaling Pathways and Emerging Therapies. Horm Metab Res. 41(9):680-6, 9/2009. e-Pub 4/2009.
2. Weaver S, Doherty DB, Jimenez C, Perrier ND. Peer-Reviewed, Evidence-Based Analysis of Vitamin D and Primary Hyperparathyroidism. World J Surg. 144(6):852-8, 3/2009. e-Pub 3/2009.
3. Jimenez C, Cabanillas ME, Santarpia L, Jonasch E, Kyle KL, Lano EA, Matin SF, Nunez RF, Perrier ND, Phan A, Rich TA, Shah B, Williams MD, Waguespack SG. Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient with von Hippel-Lindau Disease: Targeting Angiogenic Factors in Pheochromocytoma and other von Hippel-Lindau Disease-related Tumors. J Clin Endocrinol Metab 94(2):386-91, 2/2009. e-Pub 11/2008. PMID: 19017755.
4. Perrier ND, Edeiken B, Nunez R, Gayed I, Jimenez C, Busaidy N, Potylchansky E, Kee S, Vu T. A Novel Nomenclature to Classify Parathyroid Adenomas. World J Surg. 33(3):412-6, 2009 Mar;, 1/2009.
5. Habra MA, Jimenez C, Huang SC, Cote GJ, Murphy WA, Gagel RF, Hoff AO. Expression Analysis of Fibroblast Growth Factor-23, Matrix Extracellular Phosphoglycoprotein, Secreted Frizzled-Related Protein-4, and Fibroblast Growth Factor-7: Identification of Fibroblast growth factor-23 and Matrix Extracellular Phosphoglycoprotein as Major Factors Involved in Tumor-Induced Osteomalacia. Endocr Pract 14(9):1108-14, 12/2008.
6. Grubbs EG, Rafeeq S, Jimenez C, Feng L, Lee JE, Evans DB, Perrier ND. Preoperative Vitamin D Replacement Therapy in Primary Hyperparathyroidism: Safe and Beneficial? Surgery 144(6):852-8; discussion 858-9, 12/2008. PMID: 19040987.
7. Jimenez C, Burman P, Abs R, Clemmons DR, Drake WM, Hutson KR, Messig M, Thorner MO, Trainer PJ, Gagel RF. Follow-up of Pituitary Tumor Volume in Patients with Acromegaly Treated with Pegvisomant in Clinical Trials. Eur J Endocrinol 159(5):517-23, 11/2008. e-Pub 8/15/2008. PMID: 18708436.
8. Perrier ND, Kennamer DL, Bao R, Jimenez C, Grubbs EG, Lee JE, Evans DB. Posterior Retroperitoneoscopic Adrenalectomy: Preferred Technique for Removal of Benign Tumors and Isolated Metastases. Ann Surg 248(4):666-74, 10/2008. PMID: 18936580.
9. Rich TA, Jonasch E, Martin S, Waguespack SG, Stolle C, Jimenez C. A Novel von Hippel-Lindau Point Mutation Presents as Apparently Sporadic Pheochromocytoma in a Carrier of a Factor V Leiden Mutation. Cancer Investigation 26(6):642-6, 7/2008.
10. Jiménez C, Hu MI, Gagel RF. Management of Medullary Thyroid Carcinoma. Endocrinol Metab Clin North Am 37(2):481-96, 6/2008. PMID: 18502338.
11. Stava CJ, Jimenez C, Vassilopoulou-Sellin R. Endocrine Sequelae of Cancer and Cancer Treatments. J Cancer Surviv 1(4). e-Pub 11/20/2007. PMID: 18648961.
12. Hu MI, Gagel RF, Jimenez C. Bone Loss in Patients With Breast or Prostate Cancer. Curr Osteoporos Rep 5(4):170-8, 2007.
13. Jimenez C,Cote GC,Arnold A,Gagel RF,. Should Patients with Apparently Sporadic Pheochromocytomas or Paragangliomas be Screened for Hereditary Syndromes? The Journal of Clinical Endocrinology and Metabolism 91(8):2851-8, 8/2006.
14. Habra M, Jimenez C, Wallace M, Evans DB, Vassilopoulou-Sellin R. Insulinoma in a Marathon Runner Illustrating the Effects of Exercise on Insulin Sensitivity and Glucose Homeostasis. The Endocrinologist January-February 16(1):20-24, 2006.
15. Jimenez C, Gomez A, Veras L, Levis S, Roos B. Vitamin D Deficiency and Seasonal Variation in Adult South Florida Population. Journal of Clinical Endocrinology and Metabolism 90(3):1557-62, 3/2005.
16. Jimenez C, Yang Y, Kim HW, Al-Sagier F, El-Naggar A, Sellin R, Berry D, Gagel RF. Primary Hyperparathyroidism and Osteosarcoma: Examination of a Large Cohort Identifies Three Cases of Fibroblastic Osteosarcomas. Journal of Bone and Mineral Research September 20(9):1562-8, 2005.
17. Jimenez C. New Therapies Against Diabetes Mellitus: Glucagon Like Peptide-1 Derivatives. Resident and Staff Physician. Symposium Issue Vol 49, No. 12, 2003.

Invited Articles
1. Jimenez C, Hu M, Gagel R. Medullary Thyroid Carcinoma. Endocrine Clinics of North America, 2008.
Other Articles
1. Pabón N, Garavito G, Jimenez C. Adrenocortical Carcinoma: Comments from the Adrenocortical Cancer Consensus. Revista Colombiana de Cancerología Vol. 10, No. 2, 1/2006.
2. Jimenez C, Cadena E, de Francisco J, Guevara G, Garavito G. Multiple Endocrine Neoplasia Type 2: A Model for Cancer Prevention. Revista Colombiana de Cancerología Vol. 9, No 2:23-27, 12/2005.
3. Builes C, De Francisco J, Garavito G, Jimenez C. Parathyroid Carcinoma, Preoperative preparation with Bisphosphonates prevents severe Hungry Bone Syndrome. Revista de la Asociación Colombiana de Osteoporosis y Metabolismo Mineral, 12/2005.
4. Jimenez C, Garavito G. Seminars in Oncologic Emergencies: Humoral Hypercalcemia of Malignancy. Revista Colombiana de Cancerología Vol. 9, No. 2:30-35, 12/2005.
5. Jimenez C. Bone Plasticity. Editorial Revista de la Asociación Colombiana de Osteoporosis y Metabolismo Mineral, 3/2005.

Abstracts
1. Guthikonda A, Jimenez C. Thyroid Leukemia. AACE, Houston, 2009, 5/2009.
2. V.D. Cataldo1, M.A. Thompson2, B.B. Toth3, P. Sanjorjo4, S. Bourgeois4, B.N. Bekele5, C. Jimenez6, W.A. Murphy7, A.O. Huen8, S.A. Byfield8, and F.B. Hagemeister4. Zoledronic Acid for the Prevention of Bone Loss in Patients with Previously Untreated Lymphoma Undergoing Chemotherapy. ASCO, Orlando, 2009, 5/2009.
3. Callender GG, Moreno M, Jimenez C, Hu MI, Grubbs EG,. Osteocalcin: Preoperative Predictor of Bone Hunger after Parathyroidectomy. AACE, Houston 2009, 4/2009.
4. Cabanillas M, Nunez R, Williams M, Jimenez C. Suture Granulomas Represent a False Positive MIBG Result, 2nd International Symposium on Pheochromocytoma. Queens College Cambridge, UK, Sept 2008, 9/2008.
5. Jimenez C, Clemmons DR, Drake WM, Hutson KR, Thorner MO, Trainer PJ, Gagel RF. Long-Term Follow-up of Pituitary Tumor Volume in Patients with Acromegaly treated with Pegvisomant. ENDO 2005, 6/2005.
6. Jimenez C, Habra A, Busaidy N, Vasudevan A, Gagel RF, Sarlis, NJ. Capecitabine and Radiotherapy Induce Disease Stabilization in a Case of Poorly Differentiated Follicular Thyroid Carcinoma, 8/2004.
7. Busaidy NL, Hymes SR, Jimenez C, Habra MA, Sarlis NJ. Progression of Medullary Thyroid Carcinoma Manifested as Skin Metastasis with Inflammatory Features, 8/2004.
8. Busaidy N, Habra MA, Jimenez C, Gagel RF. Diabetes Mellitus: A Possible Paraneoplastic Syndrome?, 6/2004.
9. Jimenez C, Habra MA, Huang SC, El-Naggar A, Shapiro SE, Evans DB, Cote G, Gagel RF. Pheochromocytoma and Medullary Thyroid Carcinoma: A New Genotype-Phenotype Correlation of the RET Proto-Oncogene 891 Germline Mutation. J Clin Endocrinol Metab 89(8):4142-5, 6/2004. PMID: 15292360.
10. Jimenez C, Habra MA, Busaidy N, Vasudevan A, Gagel RF, Sarlis NJ. Portal Hypertension: Another Complication of Metastatic Medullary Thyroid Carcinoma, 6/2004.
11. Asper JA, Rosenthal DI, Garden AS, Clayman G, Jimenez C, Ang KK. Parathyroid Carcinoma: The Role of Postoperative Radiation Therapy (Oral Presentation), 5/2004.
12. Busaidy N, Jimenez C, Habra MA, Gagel RF. Secondary or Tertiary Hyperparathyroidism in Tumor Induced Osteomalacia, 5/2004.
13. Habra MA, Jimenez C, Busaidy N, Vassilopoulou-Sellin R. Hyperprolactinemia as Initial Manifestation of Cowden Syndrome, 4/2004.
14. Jimenez C, Burman P, Clemmons D, Drake W, Thorner M, Trainer P, Gagel RF. Long-term follow-up of Pituitary Tumor Volume in Patients with Acromegaly Treated with Pegvisomant, 2004.
15. Garavito G, Neira F, Mejia C, Restrepo L, Penagos P, Yeung, SCJ, Jimenez C. A Woman with Acromegaly, a Normal Pituitary, and a Parasellar Mass. Where is the Excessive Growth Hormone Secretion Coming From?, 12/2003.
16. Jimenez C, Kim HW, Al-Sagier F, El-Naggar A, Sellin R, Berry D, Gagel RF. Primary Hyperparathyroidism and Osteosarcoma: Examination of a Large Cohort Identifies Unique Characteristics (Oral Presentation), 9/2003.
17. Jimenez C, Maple S, Gagel R,. Bone Mineral Density in Patients with Acromegaly under Therapy with Pegvisomant. ENDO, Philadelphia 2002, 6/2003.
18. Jimenez C, Maple S, Al-Sghir F, Gagel R. Lack of Further Growth in the Size of 2 Pituitary Growth Hormone Producing Tumors After Initiation of Pegvisomant Therapy, 6/2003.
19. Jimenez C, Maple S, Schultz P, Gagel R. Treatment of Acromegaly with Pegvisomant, a Growth Hormone Receptor Antagonist, Does Not Reduce Bone Mass, 6/2003.
20. Busaidy N, Jimenez C, Habra M, Schultz P, El-Naggar A, Clayman G, Vassilopoulou-Sellin R. Parathyroid Carcinoma, The University of Texas M. D. Anderson Cancer Center Experience, 5/2003.
21. Jimenez C, Habra M, Busaidy N, Wirfel K, El-Naggar A, Vassilopoulou-Sellin R. 5. Parathyroid Carcinoma, MD Anderson Cancer Center Experience. Head and Neck Surgery Journal, 2003.
22. Roman F, Bentancourt M, Case C, Jimenez C,Wirfel K. Non-Islet Cell Tumor Hypoglycemia: Case presentation, Hormonal Evaluation and Options for Palliative Treatment, 5/2002.
23. Levis S, Gomez A, Jimenez C, Vera L, Hollis BW, Lai S, Roos B. Decreased Seasonal Variation in Vitamin D Levels in Medical Outpatients in Miami, Florida (Unites States). ENDO Denver, CO, 2003, 6/2001.
24. Gomez A, Veras L, Jimenez C, Hollis BW, Lai S, Roos B, Lewis S. Diminished Seasonal Vitamin D and PTH Changes in South Florida. Geriatrics, Chicago, IL,, 2001.
25. Levis S, Gomez A, Jimenez C, Veras L, Hollis BW, Lai S, Roos B. Sustained 25(OH) Vitamin D Levels Throughout the Year in the Elderly Population of South Florida. ECTS, Madrid, Spain May 2001, 2000.

Book Chapters
1. Jimenez C, Gagel R. Disorders affecting multiple endocrine systems. In: Harrison's Principles of Internal Medicine, 17th. McGraw Hill, 2008.
2. Rich T, Jimenez C, Evans D. Genetic Evaluation of Pheochromocytomas. Genetic Diagnosis of Endocrine Disorders. In: Endocrine Neoplasms. Ed(s) First, 2008.
3. Jimenez C. Thyroid Cancer. In: Medicina Interna (Internal Medicine), First. Colombian Association of Internal Medicine, 2006.
4. Jimenez C, Garavito G, Ramos P. Neuroendocrine Tumors of the Gastrointestinal Tract. In: Gastroenterología, Second, 2005.

Last updated: 9/14/2009